
G1 Therapeutics, Inc.
Get Full AccessDescription
- G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates.
-
Headquarters:79 Tw Alexander Dr 4501 Research Commons, Suite 100, Durham, North Carolina, United States
More -
Phone Number: +1 919-213-9835
-
Website: https://www.g1therapeutics.com
-
Employees:121
-
Revenue:$100 - 250M
-
Legal Name:G1 Therapeutics, Inc.
-
G1 Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding G1 Therapeutics, Inc.
-
Where are G1 Therapeutics, Inc.'s Headquarters?
G1 Therapeutics, Inc.'s Headquarters are in 79 Tw Alexander Dr 4501 Research Commons, Suite 100,Durham,North Carolina,United States
-
What is G1 Therapeutics, Inc.'s phone number?
G1 Therapeutics, Inc.'s phone number is +1 919-213-9835
-
What is G1 Therapeutics, Inc.'s official website?
G1 Therapeutics, Inc.'s official website is https://www.g1therapeutics.com
-
What is G1 Therapeutics, Inc.'s Revenue?
G1 Therapeutics, Inc.'s revenue is $100 - 250M
-
What is G1 Therapeutics, Inc.'s NAICS code?
G1 Therapeutics, Inc.'s NAICS code is 325412
-
How many employees are working in G1 Therapeutics, Inc.
G1 Therapeutics, Inc. has 121 employees
-
What is G1 Therapeutics, Inc.'s Industry?
G1 Therapeutics, Inc. is in the industry of Biotechnology
-
Who is G1 Therapeutics, Inc.'s CEO?
G1 Therapeutics, Inc.'s CEO is Jack Bailey